Lars Weiss

1.5k citations

28 papers · 1.0k indexed · h-index 17

Impact in

Nephrology top 1%
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins

Papers in ⓘ

Nephrology 16
- Dialysis and Renal Disease Management 9
- Chronic Kidney Disease and Diabetes 5
- Parathyroid Disorders and Treatments 3
Endocrinology, Diabetes and Metabolism 10
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Hormonal Regulation and Hypertension 3

Co-authors: Ola Samuelsson (10 shared papers)Carolyn Knight‐Gibson (8 shared papers)H. Mulec (8 shared papers)Petar Alaupovic (7 shared papers)P.-O. Attman (6 shared papers)Robert Larsson (5 shared papers)B Kron (2 shared papers)Hans Wedel (2 shared papers)
Journals: Nephrology Dialysis Transplantation (5 papers)The Nephron journals/Nephron journals (3 papers)Kidney International (3 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Journal of Clinical Microbiology (1 paper)
Partner nations: Sweden United States Netherlands

In The Last Decade

Lars Weiss

28 papers receiving 993 citations

Peers

Countries citing papers authored by Lars Weiss

Since Specialization

Citations

This map shows the geographic impact of Lars Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Weiss more than expected).

Fields of papers citing papers by Lars Weiss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Weiss. The network helps show where Lars Weiss may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Weiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Weiss Line = papers co-authored together Lars Weiss links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products Kidney International ·Bengt Rippe, Ole Simonsen, Olof Heimbürger, Anders Christensson, Börje Haraldsson, Gunnar Stelin, Lars Weiss, Finn-David Nielsen, Susanne Bro, M Friedberg, Anders Wieslander	2001	197
2	Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency Nephrology Dialysis Transplantation ·Ola Samuelsson, H. Mulec, Carolyn Knight‐Gibson, P.-O. Attman, B Kron, Robert Larsson, Lars Weiss, Hans Wedel, Petar Alaupovic	1997	179
3	Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. Journal of the American Society of Nephrology ·Ola Samuelsson, P.-O. Attman, Carolyn Knight‐Gibson, Robert Larsson, H. Mulec, Lars Weiss, Petar Alaupovic	1998	93
4	Confirmation of Nosocomial Transmission of Hepatitis C Virus by Phylogenetic Analysis of the NS5-B Region Journal of Clinical Microbiology ·Heléne Norder, Åsa Bergström, Ingrid Uhnoo, Jöran Aldén, Lars Weiss, Jan Czajkowski, Lars O. Magnius	1998	67
5	Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis Kidney International ·Per-Ola Attman, Ola Samuelsson, James B. Moberly, Ann-Cathrine Johansson, Susanne Ljungman, Lars Weiss, Carolyn Knight‐Gibson, Petar Alaupovic	1999	60
6	The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin β: results from a randomized controlled multicentre trial Nephrology Dialysis Transplantation ·Lars Weiss, Naomi Clyne, Jose Divino Fihlho, Carsten Frisenette‐Fich, Jan Kurkus, Birgitta Svensson	2000	60
7	Microalbuminuria and risk factors in type 1 and type 2 diabetic patients Diabetes Research and Clinical Practice ·Jan Cederholm, Björn Eliasson, Per-Erik Nilsson, Lars Weiss, Soffia Guðbjörnsdóttir	2004	59
8	Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension Hypertension ·Patrik Färbom, Björn Wahlstrand, Peter Almgren, Stanko Skrtic, Jan Lanke, Lars Weiss, Sverre E. Kjeldsen, Thomas Hedner, Olle Melander	2008	38
9	Continuous arteriovenous hemofiltration in the treatment of 100 critically ill patients with acute renal failure: report on clinical outcome and nutritional aspects. PubMed ·Lars Weiss, Danielson Bg, Björn Wíkström, U Hedstrand, J Wahlberg	1989	38
10	Biocompatibility and Tolerability of a Purely Bicarbonate-Buffered Peritoneal Dialysis Solution Peritoneal Dialysis International ·Lars Weiss, Bernd Stegmayr, Gudrun Malmsten, Mattias Tejde, Henrik Hadimeri, C. E. H. Siegert, J Ahlmén, Rutger Larsson, B. Ingman, Ole Simonsen, Henk W. van Hamersvelt, Ann Johansson, Britta Hylander, Michael Mayr, Per-Henrik Nilsson, Per Andersson, Tatiana De los Ríos	2009	31
11	Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency American Journal of Kidney Diseases ·Ola Samuelsson, Per‐Ola Attman, Carolyn Knight‐Gibson, H. Mulec, Lars Weiss, Petar Alaupovic	2002	27
12	The Plasma Levels of Homocysteine Are Elevated in Moderate Renal Insufficiency but Do Not Predict the Rate of Progression The Nephron journals/Nephron journals ·Ola Samuelsson, D.M. Lee, P.-O. Attman, Carolyn Knight‐Gibson, J.K. Mullen, Robert Larsson, H. Mulec, Lars Weiss, Petar Alaupovic	1999	26
13	Aspects of the relation between functional and structural cardiovascular factors in primary hypertension. Experimental studies in spontaneously hypertensive rats. PubMed ·Lars Weiss	1974	22
14	Effect of Gemfibrozil on Lipoprotein Abnormalities in Chronic Renal Insufficiency: A Controlled Study in Human Chronic Renal Disease Nephron ·Ola Samuelsson, P.-O. Attman, Carolyn Knight‐Gibson, B Kron, Robert Larsson, H. Mulec, Lars Weiss, P. Alaupovic	1997	21
15	Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease Nephrology Dialysis Transplantation ·Ola Samuelsson, Per‐Ola Attman, Rutger Larsson, H. Mulec, Lars Rymo, Lars Weiss, Anne Ricksten	2000	20
16	Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency Kidney International ·Petar Alaupovic, P.-O. Attman, Carolyn Knight‐Gibson, H. Mulec, Lars Weiss, Ola Samuelsson	2006	18
17	Five methods for measuring low-density lipoprotein cholesterol concentration in serum compared. PubMed ·G. E. Hoffmann, Renate Hiefinger, Lars Weiss, W Poppe	1985	16
18	Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure Nephrology Dialysis Transplantation ·Ola Samuelsson, P.-O. Attman, Carolyn Knight‐Gibson, Robert Larsson, H. Mulec, Hans Wedel, Lars Weiss, Petar Alaupovic	1996	14
19	Do High-flux Dialysis Membranes Affect Renal Dyslipidemia? ASAIO Journal ·Pia Ottosson, Per-Ola Attman, Cameron G. Knight, Ola Samuelsson, Lars Weiss, Petar Alaupovic	2001	13
20	Aluminum Removal with Hemodialysis, Hemofiltration and Charcoal Hemoperfusion in Uremic Patients after Desferrioxamine Infusion The Nephron journals/Nephron journals ·Lars Weiss, Bo G. Danielson, Bengt Fellström, Björn Wíkström	1989	11

About Lars Weiss

Lars Weiss is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Emergency Medical Services, Surgery and Cardiology and Cardiovascular Medicine, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (10 papers), Dialysis and Renal Disease Management (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Chronic Kidney Disease and Diabetes (5 papers), Pharmacological Effects and Toxicity Studies (3 papers), Parathyroid Disorders and Treatments (3 papers), Hormonal Regulation and Hypertension (3 papers) and Vitamin D Research Studies (2 papers). The work is most often cited by research in Nephrology (633 citations), Endocrinology, Diabetes and Metabolism (256 citations), Emergency Medical Services (100 citations), Hematology (105 citations) and Surgery (398 citations). Lars Weiss has collaborated with scholars based in Sweden, United States and Netherlands. Frequent co-authors include Ola Samuelsson, Carolyn Knight‐Gibson, H. Mulec, Petar Alaupovic, P.-O. Attman, Robert Larsson, B Kron, Hans Wedel, Ole Simonsen and Anders Christensson. Their work appears in journals such as Nephrology Dialysis Transplantation, The Nephron journals/Nephron journals, Kidney International, Clinical Chemistry and Laboratory Medicine (CCLM) and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact